Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | NSD2 | O96028 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.35 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23554898 | 0.74 | CCR1 (0.41) | CCR1ALDH1A1MAPTKDM4ENSD2 | |
| SCHEMBL3421490 | 0.73 | ALDH1A1 (0.65) | CCR1ALDH1A1P2RX7 | |
| SCHEMBL15833604 | 0.72 | MAPT (0.41) | CCR1ALDH1A1MAPTKDM4ENSD2 | |
| SCHEMBL15819411 | 0.71 | ADORA2A (0.46) | ALDH1A1MAPTKDM4ENSD2ADORA1 | |
| SCHEMBL19928112 | 0.69 | MAPT (0.39) | ALDH1A1MAPTKDM4ENSD2ADORA1 | |
| SCHEMBL21604597 | 0.69 | ADORA2A (0.37) | ALDH1A1MAPTKDM4ENSD2ADORA1 | |
| SCHEMBL31600322 | 0.68 | CYP1A2 (0.40) | ALDH1A1MAPTKDM4ENSD2ADORA1 | |
| SCHEMBL25786732 | 0.68 | MAPT (0.38) | ALDH1A1MAPTKDM4ENSD2ADORA1 | |
| SCHEMBL21604627 | 0.66 | ALDH1A1 (0.56) | ALDH1A1MAPTKDM4ENSD2 | |
| SCHEMBL31721638 | 0.66 | MAT2A (0.38) | ALDH1A1MAPTKDM4ENSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608830-A1 | HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024089155-A1 | HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-05-02 | — | — | WO | disclosed |